A CLINICAL CASE OF NON-SMALL CELL THERAPY LUNG CANCER WITH PD-L1 EXPRESSION
9469 9998 2 2024 10.34689/SH.2024.26.2.028 Immunotherapy by choosing a personalized treatment based on efficacy, favorable toxicity profile and tolerability consistent with the results of randomized clinical trials (KEYNOTE) is a promising new approach to the treatment of metastatic non-small cell lung cancer. Currently, in the treatment of non-small cell lung cancer, the range of immunotherapeutic drugs has significantly expanded, the use of which makes it possible to achieve tumor control...
Изменен: 28.04.2024Путь: Главная / Home / Publications
Результаты поиска 1 1 из 1
Начало | Пред. | 1 | След. | Конец
Сортировать по релевантности | Отсортировано по дате